Episode 124
The FDA on Paxlovid and COVID-19: What physicians need to know, Part II
In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.
February 15, 202214m 49s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.
Topics
dr troysenior medical officerpaxlovidstephanie troyharmonfdatherapeuticspart 2covid 19monoclonaldivision of antiviralsgeraldwhat physicians need to know